Literature DB >> 24996786

Pseudo-progression after stereotactic radiotherapy of brain metastases: lesion analysis using MRI cine-loops.

Ruud Wiggenraad1, Petra Bos, Antoinette Verbeek-de Kanter, Geert Lycklama À Nijeholt, Jan van Santvoort, Martin Taphoorn, Henk Struikmans.   

Abstract

Stereotactic radiotherapy (SRT) of brain metastasis can lead to lesion growth caused by radiation toxicity. The pathophysiology of this so-called pseudo-progression is poorly understood. The purpose of this study was to evaluate the use of MRI cine-loops for describing the consecutive events in this radiation induced lesion growth. Ten patients were selected from our department's database that had received SRT of brain metastases and had lesion growth caused by pseudo-progression as well as at least five follow-up MRI scans. Pre- and post SRT MRI scans were co-registered and cine-loops were made using post-gadolinium 3D T1 axial slices. The ten cine loops were discussed in a joint meeting of the authors. The use of cine-loops was superior to evaluation of separate MRI scans for interpretation of events after SRT. There was a typical lesion evolution pattern in all patients with varying time course. Initially regression of the metastases was observed, followed by an enlarging area of new contrast enhancement in the surrounding brain tissue. Analysis of consecutive MRI's using cine-loops may improve understanding of pseudo-progression. It probably represents a radiation effect in brain tissue surrounding the irradiated metastasis and not enlargement of the metastasis itself.

Entities:  

Mesh:

Year:  2014        PMID: 24996786     DOI: 10.1007/s11060-014-1519-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

Review 2.  Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

Authors:  Nancy U Lin; Eudocia Q Lee; Hidefumi Aoyama; Igor J Barani; Brigitta G Baumert; Paul D Brown; D Ross Camidge; Susan M Chang; Janet Dancey; Laurie E Gaspar; Gordon J Harris; F Stephen Hodi; Steven N Kalkanis; Kathleen R Lamborn; Mark E Linskey; David R Macdonald; Kim Margolin; Minesh P Mehta; David Schiff; Riccardo Soffietti; John H Suh; Martin J van den Bent; Michael A Vogelbaum; Jeffrey S Wefel; Patrick Y Wen
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

3.  Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors.

Authors:  Jay Jagannathan; Joshua H Petit; Karl Balsara; Richard Hudes; Lawrence S Chin
Journal:  Am J Clin Oncol       Date:  2004-10       Impact factor: 2.339

4.  Response criteria for phase II studies of supratentorial malignant glioma.

Authors:  D R Macdonald; T L Cascino; S C Schold; J G Cairncross
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

Review 5.  Adaptive radiotherapy for lung cancer.

Authors:  Jan-Jakob Sonke; José Belderbos
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

6.  The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles.

Authors:  Naosuke Nonoguchi; Shin-Ichi Miyatake; Motoi Fukumoto; Motomasa Furuse; Ryo Hiramatsu; Shinji Kawabata; Toshihiko Kuroiwa; Motomu Tsuji; Manabu Fukumoto; Koji Ono
Journal:  J Neurooncol       Date:  2011-06-18       Impact factor: 4.130

Review 7.  Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors.

Authors:  James Fink; Donald Born; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis.

Authors:  Julien Dinkel; Christian Hintze; Ralf Tetzlaff; Peter E Huber; Klaus Herfarth; Juergen Debus; Hans U Kauczor; Christian Thieke
Journal:  Radiother Oncol       Date:  2009-04-24       Impact factor: 6.280

10.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

View more
  6 in total

1.  Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.

Authors:  Luke Peng; Vishwa Parekh; Peng Huang; Doris D Lin; Khadija Sheikh; Brock Baker; Talia Kirschbaum; Francesca Silvestri; Jessica Son; Adam Robinson; Ellen Huang; Heather Ames; Jimm Grimm; Linda Chen; Colette Shen; Michael Soike; Emory McTyre; Kristin Redmond; Michael Lim; Junghoon Lee; Michael A Jacobs; Lawrence Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-24       Impact factor: 7.038

2.  Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.

Authors:  Henrik Hauswald; Alina Stenke; Jürgen Debus; Stephanie E Combs
Journal:  BMC Cancer       Date:  2015-07-23       Impact factor: 4.430

3.  Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab.

Authors:  Stephanie Du Four; Yanina Janssen; Alex Michotte; Anne-Marie Van Binst; Robbe Van den Begin; Johnny Duerinck; Bart Neyns
Journal:  Cancer Med       Date:  2018-08-21       Impact factor: 4.452

4.  MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy.

Authors:  R Bodensohn; R Forbrig; S Quach; J Reis; A-L Boulesteix; U Mansmann; I Hadi; D F Fleischmann; J Mücke; A Holzgreve; N L Albert; V Ruf; M Dorostkar; S Corradini; J Herms; C Belka; N Thon; M Niyazi
Journal:  ESMO Open       Date:  2022-03-03

5.  Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.

Authors:  Paul Lesueur; William Kao; Alexandra Leconte; Julien Geffrelot; Justine Lequesne; Joëlle Lacroix; Pierre-Emmanuel Brachet; Ioana Hrab; Philippe Royer; Bénédicte Clarisse; Dinu Stefan
Journal:  BMC Cancer       Date:  2020-02-22       Impact factor: 4.430

6.  Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery.

Authors:  Ingrid Digernes; Endre Grøvik; Line B Nilsen; Cathrine Saxhaug; Oliver Geier; Edmund Reitan; Dag Ottar Sætre; Birger Breivik; Timothy Reese; Kari Dolven Jacobsen; Åslaug Helland; Kyrre Eeg Emblem
Journal:  Adv Radiat Oncol       Date:  2018-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.